SGQ.TO Stock News Southgobi Resources Ltd (SGQ.TO) 0.58 08/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Southgobi Resources Ltd (SGQ.TO) 0.58 $SGQ.TO

SouthGobi Resources to Announce Interim Financial Results for the Three and Six Months Ended June 30, 2014 on August 11, 2014
Marketwire - Wed Jul 30, 4:59AM CDT
The board of directors of SouthGobi Resources Ltd. (TSX: SGQ)(HKSE: 1878) (the "Company" will meet on Monday, August 11, 2014 to consider and approve the interim financial results of the Company and its subsidiaries for the three and six months ended June 30, 2014. These financial results will be released before TSX market open.

Turquoise Hill Announces Sale of 29.95% Stake in SouthGobi Resources
Marketwire - Tue Jul 29, 11:33PM CDT
Turquoise Hill Resources (NYSE: TRQ) (NASDAQ: TRQ) (TSX: TRQ) (Turquoise Hill or the Company) today announced that it has entered into a share purchase agreement with National United Resources Holdings Limited (the Purchaser), a Hong Kong-based public company listed on the main board of the Stock Exchange of Hong Kong (SEHK), providing for the sale to the Purchaser of a 29.95% stake in SouthGobi Resources Ltd. (SouthGobi), an integrated coal mining, development and exploration company operating in Mongolia.

Turquoise Hill Enters Into an Agreement with National United Resources to Sell Shares Representing 29.95% of SouthGobi Resources' Total Shareholding
Marketwire - Tue Jul 29, 11:31PM CDT
SouthGobi Resources Ltd. (TSX: SGQ) (HKSE: 1878) ("SouthGobi" or the "Company" has been notified that Turquoise Hill Resources Ltd. ("Turquoise Hill" has entered into a share purchase agreement to sell a 29.95% stake in the Company to National United Resources Holdings Limited ("NUR", a Hong Kong-based public company listed on the main board of the Stock Exchange of Hong Kong Limited ("SEHK".

Turquoise Hill Announces Second Quarter 2014 Production
Marketwire - Tue Jul 15, 4:03PM CDT
Turquoise Hill Resources (NYSE: TRQ) (NASDAQ: TRQ) (TSX: TRQ) today announced the second quarter 2014 production for Oyu Tolgoi.

SouthGobi Resources Announces Select Second Quarter 2014 Operating Results
Marketwire Canada - Thu Jul 10, 6:14PM CDT
SouthGobi Resources Ltd. (TSX:SGQ)(HKSE:1878) (the "Company" or "SouthGobi" today announced select second quarter 2014 operating results. All figures are in U.S. Dollars unless otherwise stated.

Notice of Dispute Filed With the Government of Mongolia
Marketwire - Thu Jun 26, 3:06AM CDT
Following receipt of an audit report from the Mongolian Tax Authority claiming unpaid taxes, penalties and disallowed entitlements associated with the initial development of the Oyu Tolgoi mine, Turquoise Hill Resources today announced that a notice of dispute with the Government of Mongolia has been filed.

Court of Justice in Mongolia Has Set June 30, 2014 as the Trial Date for the Tax Investigation Case Against SouthGobi Sands and Three of Its Former Employees
Marketwire - Tue Jun 24, 7:00PM CDT
SouthGobi Resources Ltd. (TSX: SGQ)(HKSE: 1878) (the "Company" previously announced on May 13, 2014 that the charges for alleged violation of Mongolian tax law had been officially filed against the Company's three (3) former employees and against the Company's Mongolian subsidiary SouthGobi Sands LLC ("SGS" as "civil defendant". The case was transferred to the First Instance 2nd District Court for review by a judge in April 2014. The Company was advised on May 12, 2014 the appointed judge concluded that the investigation on the case was incomplete and ordered the case to return to the Prosecutor General for additional investigation.

Oyu Tolgoi Receives Audit Report From Mongolian Tax Authority
Marketwire - Mon Jun 23, 6:41AM CDT
Turquoise Hill Resources (NYSE: TRQ) (NASDAQ: TRQ) (TSX: TRQ) today announced that Oyu Tolgoi LLC has received an audit report from the Mongolian Tax Authority claiming unpaid taxes, penalties and disallowed entitlements associated with the initial development of the Oyu Tolgoi mine.

Hong Kong Takeovers Code to Apply to SouthGobi Resources
Marketwire - Fri Jun 20, 6:51AM CDT
Prior to the listing of the securities of SouthGobi Resources Ltd. (TSX: SGQ)(HKSE: 1878) (the "Company" on the Stock Exchange of Hong Kong Limited in 2010, the Company applied to Hong Kong's Securities and Futures Commission (the "SFC" for, and was granted, a ruling that the Company is not a public company in Hong Kong for the purposes of the Codes on Takeovers and Mergers and Share Repurchases in Hong Kong (the "Takeovers Code". Consequently the Takeovers Code has not applied to the Company since the time of its Hong Kong listing.

Turquoise Hill Appoints New Chief Financial Officer
Marketwire - Thu May 29, 6:36PM CDT
Turquoise Hill Resources today announced the appointment of Steeve Thibeault as Chief Financial Officer effective June 1, 2014. Mr. Thibeault will replace Chris Bateman, who will be leaving the company to pursue other opportunities. Mr. Bateman and Mr. Thibeault are working together to ensure a smooth transition.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading